Associated Papers
Monogenic forms of inflammatory bowel disease: Genetic mechanisms, models, and clinical implications.
Ghorbanpour A et al.
Molecular Medicine (cambridge, Mass.), 2026
Chronic enteropathy associated with solute carrier organic anion transporter family member 2A1 gene: A case report and review of literature.
Wang JY et al.
World Journal of Gastrointestinal Endoscopy, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.
Corbett RJ et al.
Nature Communications, 2025
Endocrine Alterations in Patients With Pachydermoperiostosis.
Stelmachowska-Banaś M et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
Pachydermoperiostosis Associated With a Rare SLCO2A1 Mutation: A Case Report and Literature Review.
Mohammad M et al.
Cureus, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors.
Corbett RJ et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
Characteristics of chronic enteropathy associated with SLCO2A1 gene (CEAS) in children, a unique type of monogenic very early-onset inflammatory bowel disease.
Lim JG et al.
Bmc Pediatrics, 2024
A novel variant in the SLCO2A1 gene in a Chinese patient with chronic gastroenteropathy and primary hypertrophic osteoarthropathy.
Dai Y et al.
Orphanet Journal of Rare Diseases, 2024
Genotype and phenotype characterization of primary hypertrophic osteoarthropathy type 2 and chronic enteropathy associated with SLCO2A1: Report of two cases and literature review.
Kimball TN et al.
American Journal of Medical Genetics. Part A, 2024
Attenuated Expression of SLCO2A1 Caused by DNA Methylation in Pediatric Inflammatory Bowel Disease.
Ito N et al.
Inflammatory Bowel Diseases, 2023
Identification of three novel mutations in SLCO2A1 in Asian-Indians with Pachydermoperiostosis.
Pasumarthi D et al.
The Indian Journal of Medical Research, 2023
A patient with pachydermoperiostosis harboring SLCO2A1 variants with a history of differentiating from acromegaly.
Nakano Y et al.
Bone Reports, 2023
Clinical and Genetic Characteristics of Korean Patients Diagnosed with Chronic Enteropathy Associated with SLCO2A1 Gene: A KASID Multicenter Study.
Hong HS et al.
Gut and Liver, 2022
Genomic analyses of 10,376 individuals in the Westlake BioBank for Chinese (WBBC) pilot project.
Cong PK et al.
Nature Communications, 2022
[A case of chronic enteropathy associated with SLCO2A1 gene diagnosed by capsule endoscopy and successfully treated by ferric carboxymaltose].
Harada A et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-enterology, 2022
Four Variants of SLCO2A1 Identified in Three Chinese Patients with Chronic Enteropathy Associated with the SLCO2A1 Gene.
Huang H et al.
Digestive Diseases and Sciences, 2021
Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations.
Oiwa T et al.
The Journal of Dermatology, 2021
Primary hypertrophic osteoarthropathy with severe arthralgia identified by gene mutation of SLCO2A1.
Ishizuka T et al.
Modern Rheumatology Case Reports, 2021
The ATP-Releasing Maxi-Cl Channel: Its Identity, Molecular Partners and Physiological/Pathophysiological Implications.
Sabirov RZ et al.
Life (basel, Switzerland), 2021
Genetics Evaluation of Targeted Exome Sequencing in 223 Chinese Probands With Genetic Skeletal Dysplasias.
Lv S et al.
Frontiers in Cell and Developmental Biology, 2021
Obscure gastrointestinal bleeding caused by congenital enteropathy in a Chinese young child-a case report.
Fang Y et al.
Bmc Pediatrics, 2020
Characteristic Facial Appearance Was the Key to Diagnosing Chronic Enteropathy Associated with SLCO2A1-associated Primary Hypertrophic Osteoarthropathy.
Sonoda A et al.
Internal Medicine (tokyo, Japan), 2020
A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy.
Jimbo K et al.
Plos One, 2020
Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene.
Li Z et al.
The British Journal of Dermatology, 2019
Distinction between Chronic Enteropathy Associated with the SLCO2A1 Gene and Crohn's Disease.
Yanai S et al.
Gut and Liver, 2019
Novel SLCO2A1 mutations cause gender-differentiated pachydermoperiostosis.
Yuan L et al.
Endocrine Connections, 2018
Successful azathioprine treatment in an adolescent with chronic enteropathy associated with SLCO2A1 gene: A case report.
Eda K et al.
Medicine, 2018
Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease.
Umeno J et al.
Journal of Gastroenterology, 2018
Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.
Hou Y et al.
Bone, 2018
A male Korean who was diagnosed with chronic enteropathy associated with SLCO2A1 (CEAS): case report with literature review.
Sun X et al.
Bmj Open Gastroenterology, 2018
Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins.
Nakanishi T et al.
The Aaps Journal, 2017
Complete type of pachydermoperiostosis with a novel mutation c.510G>A of the SLCO2A1 gene.
Nakazawa S et al.
The Journal of Dermatology, 2017
Chronic Enteropathy Associated With SLCO2A1 Gene [CEAS]-Characterisation of an Enteric Disorder to be Considered in the Differential Diagnosis of Crohn's Disease.
Hosoe N et al.
Journal of Crohn's & Colitis, 2017
Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.
Guo T et al.
Molecular Medicine Reports, 2017
Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.
Lee S et al.
Journal of Korean Medical Science, 2016
A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter.
Umeno J et al.
Plos Genetics, 2015
Case of pachydermoperiostosis with solute carrier organic anion transporter family, member 2A1 (SLCO2A1) mutations.
Minakawa S et al.
The Journal of Dermatology, 2015
Complete form of pachydermoperiostosis with SLCO2A1 gene mutation in a Korean family.
Kim HJ et al.
The Journal of Dermatology, 2015
The complete type of pachydermoperiostosis: a novel nonsense mutation p.E141* of the SLCO2A1 gene.
Niizeki H et al.
Journal of Dermatological Science, 2014
Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation-case report and review of literature.
Madruga Dias JA et al.
Seminars in Arthritis and Rheumatism, 2014
A novel mutation in the SLCO2A1 gene in a Chinese family with primary hypertrophic osteoarthropathy.
Zhang Z et al.
Gene, 2013
Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z et al.
The Journal of Clinical Endocrinology and Metabolism, 2013
Mutations in the prostaglandin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing.
Busch J et al.
The Journal of Investigative Dermatology, 2012
Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis.
Sasaki T et al.
Journal of Dermatological Science, 2012
Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.
Zhang Z et al.
American Journal of Human Genetics, 2012
Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy.
Cheng R et al.
European Journal of Dermatology : Ejd, 0